Sigma-Aldrich plans to spend $370 million to acquire JRH Biosciences of Lenaxa, Kan., a 400-employee sera and cell-culture product manufacturing firm with $150 million in sales in 2004, the company said Tuesday.

With $134 million in cash on hand at the end of the quarter ending Sept. 30, Sigma will need some $200 million in additional cash to pay for the acquisition. The company will take out short-term and three-year term debt to finance the acquisition, Sigma said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.